“Imag(in)ing SEEG With Multimodal Integration” will give epilepsy providers clear insights on how multimodal studies contribute to the pre-SEEG workup and surgical strategy formation. Don’t miss this three-day CME workshop in March.
Minimizing risk of sudden unexpected death in epilepsy is one reason among many to make sure our patients with epilepsy reach the point of zero seizures.
We’ve developed an artificial intelligence system to automatically detect seizures from long-term EEG recordings in an epilepsy monitoring unit. Strong performance in early datasets hints at big potential implications for epilepsy diagnosis and care.
Researchers have developed the first polygenic risk score that distinguishes on a cohort level between patients with epilepsy and controls, as well as between patients with generalized and focal epilepsies.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A large data-mining study shows that digital conversations provide a needed emotional outlet for teens and adults coping with epilepsy and can help physicians better understand their patients’ mindsets.
New funding is empowering our clinicians and scientists to combine genomic, molecular and neuroimaging expertise at a heightened level to refine the individualization of epilepsy care.
Child neurologists are starting to recommend epilepsy surgery sooner rather than later for their patients with uncontrolled seizures. Here’s why, along with tips for reassuring reluctant parents.
World experts on FCD are updating the classification of this group of drug-resistant focal epilepsies. This comprehensive CME summit will give a preview of the changes and the evidence behind them.
From increased risks to effective screening approaches, special pediatric considerations and the role of medications, our expert shares insights on the intersection of seizures and suicidality.
Median seizure reduction was substantially greater after nine years of therapy than after three years, reveals a long-term prospective study of the implantable RNS neuromodulation system.